Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters?
Wakefield
L M
LM
Laboratory of Chemoprevention and Medicine Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Letterio
J J
JJ
Geiser
A G
AG
Flanders
K C
KC
O'Shaughnessy
J
J
Roberts
A B
AB
Sporn
M B
MB
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D002273:Carcinogens / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D018450:Disease Progression; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced* / Q000517:prevention & control; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D015854:Up-Regulation / Q000187:drug effects
D016588:Anticarcinogenic Agents; D002273:Carcinogens; D016212:Transforming Growth Factor beta